Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
Medicaid MCO Provider Tax Final Rule Summary
Protect and Preserve 340B for Children’s Hospitals
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
CHA responded to two proposed rules on Medicaid funding and Hospital Conditions of Participation.
Feb. 18, 2026
Medicaid MCO Provider Tax Final Rule Summary
This summary outlines the key provisions relevant to children’s hospitals within the Medicaid managed care organization (MCO) provider tax final rule.
Feb. 17, 2026
Protect and Preserve 340B for Children’s Hospitals
The 340B program ensures access to care for children.
Feb. 12, 2026
